Artivion | CRY - Capitaux Propres Et Réserves

Prix De L'Action
37.04
Variation Quotidienne
-0.82 -2.17%
Mensuellement
-6.49%
Annuel
53.18%
Q1 Prévisions
35.91




Capitaux Propres Et Réserves Changement Date
Abbott USD 52.13B 1.3B 2025-12
Accuray USD 61.87M 19.3M 2025-09
AngioDynamics USD 185.87M 898K 2025-02
Artivion USD 438.69M 18.79M 2025-09
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Inogen USD 197.18M 2.32M 2025-09
Integra LifeSciences USD 1.04B 5.89M 2025-12
J&J USD 78.47B 0 2025-09
Mesa Laboratories USD 186.69M 8.22M 2025-12
Orthofix International USD 442.49M 15.86M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
ResMed USD 6.32B 199.61M 2025-12
Stryker USD 21.78B 594M 2025-09
Surmodics USD 118.9M 753K 2024-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Terumo JPY 1.52T 84.79B 2025-12
Trinity Biotech USD -54.72M 5.18M 2025-09